The Wall Street Journal reports that Pfizer will be able to deliver 100 million doses of the Corona Ticker by 2021. Yet they are confident about this supply. However, they will not be able to provide the 100 million vaccines they promised this year. They said they would be able to supply 50 million corona vaccines worldwide by the end of this year due to the crisis in the supply chain.
According to the New York Daily News, a Pfizer spokesman said it was taking longer than expected to get the raw material for the vaccine. Besides, the results of the clinical trial were also delayed.
People around the world, including the United States, are now waiting for the corona vaccine. The first good news was given by Pfizer and Bioentech. The United Kingdom approved the Pfizer vaccine on December 2, which is 95 percent effective in preventing corona. In the United States, it is awaiting FDA approval.